|
|
|
-
Thursday, December 5, 2024
|
|
|
Press Releases |
|
|
|
Monday, December 2, 2024 |
|
MeAI Sees Strong Support from Top Launchpad CEOs Following Sold-Out IDO |
MeAI, a leading innovator in AI and DeSci, announces the listing of its native token, $MEAI, following a successful Initial Dex Offering (IDO). more info >> |
|
MeAI Sees Strong Support from Top Launchpad CEOs Following Sold-Out IDO |
MeAI, a leading innovator in AI and DeSci, announces the listing of its native token, $MEAI, following a successful Initial Dex Offering (IDO). more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
日医工と富士通、AIの活用により医薬品製造DXへの取り組みを推進
Dec 5, 2024 10:15: JST
|
|
|
三菱商事、米国DAC事業会社Heirloom Carbon Technologies, Inc社への出資参画について
Dec 5, 2024 10:00: JST
|
|
|
Momomi(R) Home Product Brand Launches in Singapore
Dec 5, 2024 09:00 HKT/SGT
|
|
|
TACACS.net: Strengthening Network Security with Native Active Directory Integration
Dec 5, 2024 06:30 HKT/SGT
|
|
|
Maxon One Winter Release Brings Holiday Cheer from Concept to Render
Dec 5, 2024 00:00 HKT/SGT
|
|
|
中信国际电讯CPC荣获三项业界大奖 内外展现网络安全实力
Dec 4, 2024 23:05 HKT/SGT
|
|
|
中信國際電訊CPC榮獲三項業界大獎 內外展現網絡安全實力
Dec 4, 2024 23:00 HKT/SGT
|
|
|
Autobrains and JOYNEXT Revolutionize Smart Camera Solution Powered by Autobrains' Affordable Safety ADAS Software
Dec 4, 2024 22:20 HKT/SGT
|
|
|
CITIC Telecom CPC's Internal and External Cybersecurity Excellence Honored with 3 Industry Awards
Dec 4, 2024 22:10 HKT/SGT
|
|
|
25th Hong Kong Forum concludes successfully
Dec 4, 2024 22:00: JST
|
|
|
Naoris Protocol announces World's First Post-Quantum DePIN for Cybersecurity & Digital Trust ahead of Testnet
Dec 4, 2024 21:26 HKT/SGT
|
|
|
25th Hong Kong Forum concludes successfully
Dec 4, 2024 21:00 HKT/SGT
|
|
|
DENSO Signs Memorandum of Understanding with Canatu of Finland for Practical Application of Carbon Nanotube Technology
Dec 4, 2024 17:51 JST
|
|
|
Sweetness Affecting Both the Young and Old: Prevent Diabetes with LAC This World Diabetes Day
Dec 4, 2024 14:30 HKT/SGT
|
|
|
Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy
Dec 4, 2024 11:08 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|
Copyright © 2024 ACN Newswire - Asia Corporate News Network |
|
|
|
| |